鲁克索利丁尼 (Ruxolitinib) 通过恢复中酶体 stromal 细胞功能的急性移植对宿主病来改善造血再生
Yan Lin1, Quan Gu2,3, Shihong Lu2,3
1State Key Laboratory of Experimental Hematology, Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Soochow University, Changzhou, China.
The Journal of clinical investigation
|June 20, 2023
概括
在急性移植与宿主疾病 (aGVHD) 模型中,鲁克索利提尼布恢复了骨髓中介质 stromal 细胞 (BMSC) 功能. 这种JAK1/2抑制剂通过直接向BMSCs来改善造血功能障碍,提供了一个潜在的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 急性移植对宿主疾病 (aGVHD) 是异性造血干细胞移植后的一种严重并发症.
- 在aGVHD中,造血功能障碍与骨髓 (BM) 利基损伤有关,但机制尚不清楚.
研究的目的:
- 调查aGVHD对骨髓的影响,特别是对骨髓中细胞 (BMSCs) 的影响.
- 通过向BMSCs来评估ruxolitinib在改善aGVHD相关的造血功能障碍方面的治疗潜力.
主要方法:
- 采用了一种与Haplo-MHC匹配的移植aGVHD小鼠模型.
- 在非血造性BM细胞上进行单细胞RNA-Seq以分析转录变化.
- 使用功能测定和患者样本验证的结果.
主要成果:
- aGVHD严重影响了BMSCs,降低了它们的比率,损害了新陈代谢,分化和造血支持.
- 卢克索利提尼布治疗直接改善了BMSC功能,增强了细胞的增殖,分化,线粒体新陈代谢以及与造血干细胞/原始细胞的交叉交流.
- 卢克索利提尼布抑制了JAK2/STAT1通路,导致持续的BMSC功能改善和更好的供体血液形成支持.
结论:
- BMSC功能障碍是aGVHD中血液形成障碍的关键因素.
- 鲁克索利提尼布通过JAK2/STAT1通路直接恢复BMSC功能,改善aGVHD中的造血功能障碍.
- 在小鼠模型中发现的结果在人类样本中得到了验证,支持ruxolitinib的治疗潜力.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:22Bone Marrow Sampling and Transplants
363
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:19Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K